EB 148: WHO’s COVID-19 Technology Access Pool (C-TAP) comes under scrutiny

On Tuesday, 19 January 2021, the World Health Organization’s (WHO) Executive Board discussed the COVID-19 response. In these discussions, Knowledge Ecology International (KEI), and Health Action International (HAI) expressed concerns over WHO’s leadership of the COVID-19 Technology Access Pool (C-TAP).… Continue Reading

KEI Comments to NIH on Exclusive and Co-Exclusive Licenses to Senti Bio

Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) on January 12, 2021 regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Chimeric Antigen Receptor (CAR) Therapies for the Treatment of FMS-Like… Continue Reading

KEI Comments on NIH Exclusive License to Morphiex for Cancer Treatment

(Update: The NIH provided a response to our comments on January 19, 2021) On January 12, 2021, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Use… Continue Reading

WHO informal consultation (3 December 2020) addressed concerns on price transparency and shortages

On Monday, 11 January 2021, the secretariat of the World Health Organization (WHO) published an 18 page report on the Global strategy and plan of action on public health, innovation and intellectual property (EB148/10). The Director-General’s report contains a detailed… Continue Reading